Skip to main content
Premium Trial:

Request an Annual Quote

OncoDNA Inks Russian Distribution Deal With Genext

NEW YORK (GenomeWeb) – Belgian diagnostics firm OncoDNA said today that it has signed an agreement under which its tumor profiling products and services will be offered in the Russian Federation by Genext.

Under the deal, Genext will market and distribute OncoDNA's OncoDeep solid tumor test; its OncoTrace and OncoSelect liquid biopsy tests; its OncoStrat&Go solid and liquid biopsy combination; and its OncoKDM data interpretation and reporting software.

Additional terms were not disclosed.

OncoDNA has signed a number of distribution agreements for its products in recent years including ones with CyberKnife Sigulda covering Latvia, Everything Genetic in the UK, BioHisto Maroc in Morocco, and Shchurko in Belarus.

In 2016, Genext became the exclusive distributor of Premaitha Health's Iona non-invasive prenatal screening test in Russia.

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.